What DSIP / Selank Blend actually is

This blend pairs DSIP (delta sleep-inducing peptide) with Selank (anxiolytic tuftsin analogue) in a single subcutaneous injection. DSIP addresses sleep architecture; Selank addresses daytime anxiety and HPA-axis tone.¹

The pairing is particularly useful in patients whose sleep disturbance is driven by anxiety — addressing both the nocturnal and daytime components in one protocol. Selank’s non-sedating anxiolysis means daytime cognition is preserved.²

At Luxbae, DSIP / Selank Blend is prescribed and supervised by Dr. Ernst von Schwarz, MD, PhD after a complimentary medical consultation.

Mechanism — Sleep architecture plus anxiolysis

DSIP on delta-wave amplitude and GABAergic sleep architecture; Selank on GABAergic anxiety pathways and BDNF tone.¹

What the research shows

Sleep depth. DSIP’s delta-wave amplitude effects.¹

Anxiolysis. Selank’s non-sedating anxiety reduction.²

Non-dependence. Neither peptide produces tolerance or dependence in documented use.

Side effects: Mild injection-site reactions, occasional vivid dreams, rare daytime drowsiness.

FDA note: Neither component is FDA-approved; prescribed as compounded protocol.

DSIP / Selank Blend FAQ

How does this differ from a sleeping pill?
Architecture not sedation; anxiolysis without daytime impairment.

Daytime use?
Pre-sleep dosing is standard given DSIP’s sleep emphasis.

References

1. Schoenenberger GA, Monnier M. Delta-EEG-sleep-inducing peptide. Proc Natl Acad Sci USA. 1977;74(3):1282-1286.
2. Zozulia AA, Neznamov GG, et al. Efficacy of selank. Zh Nevrol Psikhiatr. 2008.
3. Pollard BJ, Pomfrett CJ. Delta sleep-inducing peptide. Eur J Anaesthesiol. 2001;18(7):419-422.